Bioxytran (BIXT) Gross Profit (2010 - 2018)
Bioxytran (BIXT) posted Gross Profit of $12195.0 for Q2 2018, up 730.88% sequentially from -$1933.0 in Q1 2018, and down 39.26% YoY from $20076.0 in Q2 2017.
Bioxytran (BIXT) Gross Profit (2010 - 2018) Analysis & Trends
Bioxytran has reported Gross Profit for 9 years, with the latest figure at $12195.0 in Q2 2018.
- Quarterly Gross Profit fell 39.26% year-over-year to $12195.0 in Q2 2018, while the trailing twelve-month figure through Jun 2018 was $83757.0 (down 25.56% YoY) and the FY2017 annual result came in at $87098.0, down 42.01% from the prior year.
- Gross Profit grew to $12195.0 in Q2 2018 per BIXT's latest filing, from -$1933.0 in the prior quarter.
- Over five years, Gross Profit peaked at $154158.0 in Q1 2014 and troughed at -$77551.0 in Q4 2014.
- A 5-year average of $27123.9 and a median of $22959.5 in 2014 frame the typical range for Gross Profit.
- The sharpest annual moves came in 2014 and 2016: Gross Profit tumbled 212.09% in 2014, then soared 844.09% in 2016.
- Over 5 years, Gross Profit stood at -$77551.0 in 2014, then soared by 93.81% to -$4802.0 in 2015, then jumped by 844.09% to $35731.0 in 2016, then plunged by 118.46% to -$6595.0 in 2017, then soared by 284.91% to $12195.0 in 2018.
- According to Business Quant data, Gross Profit over the past three periods registered $12195.0, -$1933.0, and -$6595.0 for Q2 2018, Q1 2018, and Q4 2017 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.40 Bn | 131.55 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 86.53 Bn | 78.54 Bn | 3.93 Bn |
| 3 | Argenx Se | 65.20 Bn | 60.02 Bn | 1.37 Bn |
| 4 | Moderna | 60.40 Bn | 55.26 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 42.17 Bn | 37.07 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.36 Bn | 28.05 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.74 Bn | 10.34 Bn | 668.28 Mn |
| 8 | Insmed | 27.45 Bn | 26.29 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.17 Bn | 26.33 Bn | - |
| 10 | Bioxytran | 2.29 Mn | 2.04 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2018 | 12,195.00 |
| Jun 30, 2018 | 12,195.00 |
| Mar 31, 2018 | -1,933.00 |
| Mar 31, 2018 | -1,933.00 |
| Dec 31, 2017 | -6,595.00 |
| Dec 31, 2017 | -6,595.00 |
| Sep 30, 2017 | 80,090.00 |
| Sep 30, 2017 | 80,090.00 |
| Jun 30, 2017 | 20,076.00 |
| Jun 30, 2017 | 20,076.00 |
| Mar 31, 2017 | -6,237.00 |
| Mar 31, 2017 | -6,237.00 |
| Dec 31, 2016 | 35,731.00 |
| Dec 31, 2016 | 35,731.00 |
| Sep 30, 2016 | 62,940.00 |
| Sep 30, 2016 | 62,940.00 |
| Jun 30, 2016 | 36,801.00 |
| Jun 30, 2016 | 36,801.00 |
| Mar 31, 2016 | 14,719.00 |
| Mar 31, 2016 | 14,719.00 |